Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product(Glaucoma Drainage Device (Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents)), By Surgery Method(Traditional Glaucoma Surgery (Trabeculectomy, Tube Shunt Surgery), Minimal Invasive Glaucoma Surgery (Trabecular Meshwork Bypass, Suprachoroidal Space Implants), By End-use(Hospitals, Ophthalmic Clinics, Others), By Region - Industry Forecast 2024-2031

Global Glaucoma Surgery Devices Market size was valued at USD 1.40 billion in 2022 and is poised to grow from USD 1.47 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 4.70% during the forecast period (2024-2031).

The glaucoma surgery devices market is poised for substantial growth in the future, driven by key market factors that dominate the industry. One of the major drivers is the increasing global prevalence of glaucoma, fueled by the growing aging population. As glaucoma incidence rises, there is a growing demand for effective surgical interventions. Furthermore, advancements in surgical techniques and technologies have significantly enhanced the success rates and safety of glaucoma surgeries, further propelling market growth. Minimally invasive procedures, such as glaucoma drainage devices and laser systems, have gained traction due to their ability to reduce complications and improve patient outcomes. This shift towards less invasive approaches has contributed to the expansion of the market. Additionally, the rising awareness among patients and healthcare professionals about the importance of early detection and treatment of glaucoma has resulted in increased adoption of surgical interventions, driving market growth. Favorable reimbursement policies and the presence of well-established healthcare infrastructure in developed regions like North America and Europe have also played a significant role in the market's expansion.

One prominent trend in the glaucoma surgery devices market is the growing adoption of minimally invasive glaucoma surgery (MIGS) techniques. MIGS procedures, such as trabecular micro-bypass stents and suprachoroidal shunts, offer several advantages over traditional glaucoma surgeries. They are less invasive, require shorter recovery times, and have a lower risk of complications. MIGS techniques also allow for combined procedures with cataract surgery, providing convenience to patients and reducing the need for additional surgeries. The increasing focus on patient-centric care and the demand for improved surgical outcomes are driving the adoption of MIGS techniques, which is expected to continue driving market growth.

US Glaucoma Surgery Devices Market is poised to grow at a sustainable CAGR for the next forecast year.